![](https://i0.wp.com/mingooland.com/wp-content/uploads/2021/01/acastro_200428_1777_coronavirus_0002.0.0.jpg?resize=700%2C466&ssl=1)
It’s no secret that the US is struggling to distribute coronavirus vaccines; some states haven’t received enough doses, and finding an appointment on sign-up websites has been a chaotic experience. A new report in MIT Technology Review looks at why, almost a year into the pandemic, the Centers for Disease Control and Prevention seemed totally unprepared for actually getting shots into people’s arms.
According to Technology Review, the agency knew it needed a robust, one-stop shop that could be used by patients, clinics, employers, and government officials. But instead, the CDC spent $44 million on something called the Vaccine Administration Management System —-VAMS— built by consulting firm Deloitte (via no-bid contracts) which was so…